Fadi Bou-Abdallah

Prof. Fadi Bou-Abdallah

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
Fadi Bou-AbdallahFadi Bou-Abdallah
Fadi Bou-Abdallah

4 December 2008 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
Fadi Bou-AbdallahFadi Bou-Abdallah
Fadi Bou-Abdallah
GZGuanghua Zhao
Guanghua Zhao
GBGiorgio Biasiotto
Giorgio Biasiotto
MPMaura Poli
Maura Poli
Paolo ArosioPaolo Arosio
Paolo Arosio
NCN. Dennis Chasteen
N. Dennis Chasteen

1 July 2021 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
GSGideon L. Smith
Gideon L. Smith
ARAliaksandra A. Reutovich
Aliaksandra A. Reutovich
ASAyush K. Srivastava
Ayush K. Srivastava
RRRuth E. Reichard
Ruth E. Reichard
CWCass H. Welsh
Cass H. Welsh
Fadi Bou-AbdallahFadi Bou-Abdallah
Fadi Bou-Abdallah

7 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
FHFabian Hoelzgen
Fabian Hoelzgen
TNThuy T. P. Nguyen
Thuy T. P. Nguyen
EKElina Klukin
Elina Klukin
MBMohamed Boumaiza
Mohamed Boumaiza
ASAyush K. Srivastava
Ayush K. Srivastava
GFGabriel A. Frank
Gabriel A. Frank
The interaction between nuclear receptor coactivator 4 (NCOA4) and the iron storage protein ferritin is a crucial component of cellular iron homeostasis. The binding of NCOA4 to the FTH1 subunits of ferritin initiates ferritinophagy—a ferritin-specific autophagic pathway leading to the release of the iron stored inside ferritin. The dysregulation of NCOA4 is associated with several diseases, including neurodegenerative disorders and cancer, highlighting the NCOA4-ferritin interface as a prime target for drug development. Here, we present the cryo-EM structure of the NCOA4-FTH1 interface, resolving 16 amino acids of NCOA4 that are crucial for the interaction. The characterization of mutants, designed to modulate the NCOA4–FTH1 interaction, is used to validate the significance of the different features of the binding site. Our results explain the role of the large solvent-exposed hydrophobic patch found on the surface of FTH1 and pave the way for the rational development of ferritinophagy modulators.

18 July 2017 in Biochemistry
Verified
Journal Article
Closed access
MMMatthew Mehlenbacher
Matthew Mehlenbacher
MPMaura Poli
Maura Poli
Paolo ArosioPaolo Arosio
Paolo Arosio
PSPaolo Santambrogio
Paolo Santambrogio
SLSonia Levi
Sonia Levi
Fadi Bou-AbdallahFadi Bou-Abdallah
Fadi Bou-Abdallah

5 November 2018 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Fadi Bou-AbdallahFadi Bou-Abdallah
Fadi Bou-Abdallah
JPJohn J. Paliakkara
John J. Paliakkara
GMGalina Melman
Galina Melman
AMArtem Melman
Artem Melman
Ferritins are highly conserved supramolecular protein nanostructures composed of two different subunit types, H (heavy) and L (light). The two subunits co-assemble into a 24-subunit heteropolymer, with tissue specific distributions, to form shell-like protein structures within which thousands of iron atoms are stored as a soluble inorganic ferric iron core. In-vitro (or in cell free systems), the mechanisms of iron(II) oxidation and formation of the mineral core have been extensively investigated, although it is still unclear how iron is loaded into the protein in-vivo. In contrast, there is a wide spread belief that the major pathway of iron mobilization from ferritin involves a lysosomal proteolytic degradation of ferritin, and the dissolution of the iron mineral core. However, it is still unclear whether other auxiliary iron mobilization mechanisms, involving physiological reducing agents and/or cellular reductases, contribute to the release of iron from ferritin. In vitro iron mobilization from ferritin can be achieved using different reducing agents, capable of easily reducing the ferritin iron core, to produce soluble ferrous ions that are subsequently chelated by strong iron(II)-chelating agents. Here, we review our current understanding of iron mobilization from ferritin by various reducing agents, and report on recent results from our laboratory, in support of a mechanism that involves a one-electron transfer through the protein shell to the iron mineral core. The physiological significance of the iron reductive mobilization from ferritin by the non-enzymatic FMN/NAD(P)H system is also discussed.